The approval will help ease supply shortages experienced by pharmacy admixture programs, according to the company.
“Having a new source for 15 percent amino acids may give healthcare providers one less thing to worry about,” said Rob Albert, senior vice president and chief marketing officer, in the release.
B. Braun is headquartered in Bethlehem, Pa.
Related Articles on B. Braun:
B. Braun to Display Advancements in Safety and Education at APIC
B. Braun Launches addEASE BC2000 Binary Connector
B. Braun Extends Supply Agreement With NxStage Medical
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
